Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Organogenesis Holdings Inc 85 Dan Road Canton MA 02021 USA

www.organogenesis.com Employees: 869 P: 781-575-0775

Sector:

Medical

Description:

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

Key Statistics

Overview:

Market Capitalization, $K 473,382
Enterprise Value, $K 337,232
Shares Outstanding, K 126,912
Float, K 85,031
% Float 67.00%
Short Interest, K 13,038
Short Float 10.27%
Days to Cover 20.65
Short Volume Ratio 0.33
% of Insider Shareholders 33.00%
% of Institutional Shareholders 49.57%

Financials:

Annual Sales, $ 482,040 K
Annual Net Income, $ 860 K
Last Quarter Sales, $ 150,860 K
Last Quarter Net Income, $ 21,570 K
EBIT, $ -8,380 K
EBITDA, $ 16,990 K

Growth:

1-Year Return 2.43%
3-Year Return 45.70%
5-Year Return -71.98%
5-Year Revenue Growth 84.70%
5-Year Earnings Growth 97.62%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.18 on 11/06/25
Next Earnings Date 02/26/26 [--]
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr 300.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ORGO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 20.78
Price/Earnings to Growth N/A
Return-on-Equity % 4.01%
Return-on-Assets % 2.06%
Profit Margin % 0.18%
Debt/Equity 0.00
Price/Sales 1.02
Price/Cash Flow 17.92
Price/Book 1.86
Book Value/Share 2.01
Interest Coverage -0.82
60-Month Beta 1.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar